[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350427-105":59,"doc-detail-350427-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-multi-gene-urinary-extracellular-vesicle-mrna-panel-as-a-noninvasive-biomarkers-for-prostate-cancer-detection","A multi-gene urinary extracellular vesicle mRNA panel as a noninvasive biomarkers for prostate cancer detection","","Prostate cancer detection urgently needs improved noninvasive biomarkers because PSA has limited specificity and contributes to overdiagnosis and unnecessary biopsies. Urinary extracellular vesicles (UEVs) were isolated from 15 healthy individuals and 25 patients, then characterized by NTA, TEM, and western blotting. Six PCa-associated genes were measured by qRT-PCR and evaluated using logistic regression with ROC analysis. All six genes were significantly upregulated in patients, and combined or simplified panels showed strong diagnostic AUC performance, with PSA correlating to Gleason score.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-multi-gene-urinary-extracellular-vesicle-mrna-panel-as-a-noninvasive-biomarkers-for-prostate-cancer-detection/350427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-multi-gene-urinary-extracellular-vesicle-mrna-panel-as-a-noninvasive-biomarkers-for-prostate-cancer-detection/350427.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are noninvasive biomarkers needed for prostate cancer detection?","Question",{"text":112,"@type":113},"PSA remains widely used, but its low specificity can lead to overdiagnosis and unnecessary biopsies. Noninvasive biomarkers can improve early detection and reduce patient burden and anxiety.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were urinary extracellular vesicles (UEVs) obtained and validated in the study?",{"text":117,"@type":113},"UEVs were isolated from healthy individuals and prostate cancer patients using polyethylene glycol (PEG) precipitation, then characterized by NTA, TEM, and western blotting.",{"name":119,"@type":110,"acceptedAnswer":120},"Which gene models performed best for distinguishing prostate cancer patients from healthy individuals?",{"text":121,"@type":113},"A combined six-gene logistic model achieved an AUC of 0.96, while a simplified three-gene panel (AGR2, SPDEF, PCA3) achieved an AUC of 0.954, showing strong diagnostic potential.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350427,1790158631,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA multi-gene urinary extracellular vesicle mRNA panel as a noninvasive biomarkers for prostate cancer detection  \nSreekanth Patnam1,2, Aditya Koppula5, Sarwareddy Kartik Kumar1, Supriya Thalakanti1, Rajesh V. Bendre6, Sanjai Addla3􀀍 & Sasidhar Venkata Manda1,4􀀍  \nProstate cancer (PCa) remains one of the most common malignancies in men older than 50 globally and in India. Although prostate-specific antigen (PSA) remains the standard diagnostic tool, its low specificity leads to overdiagnosis and unnecessary biopsies, highlighting the need for improved noninvasive biomarkers. Urinary extracellular vesicles (UEVs) have emerged as a promising, non-invasive source of molecular biomarkers, particularly RNA, for cancer detection. This study evaluated the diagnostic potential of six PCa associated genes (AGR2, ERG, PTEN, PCA3, AMACR, SPDEF) in UEVs. UEVs were isolated from 15 healthy individuals and 25 PCa patients via polyethylene glycol (PEG) precipitation and characterized by NTA, TEM and western blotting. Gene expression was quantified using qRT-PCR, and diagnostic performance was assessed using logistic regression models and receiver operating characteristic (ROC) analysis. Our results showed that all six genes (AGR2, ERG, PTEN, PCA3, AMACR and SPDEF) were significantly upregulated in PCa patients (p \u003C 0.05) compared to healthy individuals. ROC analyses of these genes yielded area under the curve (AUC) of 0.821, 0.754, 0.746,0.746, 0.730, 0.722 respectively. A combined six-gene logistic model achieved anAUC of 0.96, while a simplified three-gene model1 (AGR2, SPDEF, PCA3) emerged as the most parsimonious model with anAUC of 0.954.Gene expression did not correlate with Gleason score or tumor stage, whereas PSA correlated with higher Gleason score (p = 0.01). These findings highlight the potential of UEVderived multigene mRNA panels to serve as non-invasive biomarkers for PCa detection.  \nKeywords Prostate cancer, Urinary extracellular vesicles, mRNA biomarkers, Non-invasive diagnostics, Logistic regression, Healthy individuals  \nProstate cancer (PCa) is the most diagnosed malignancy and remains a second leading cause of cancer-related mortality in men worldwide with an estimated 1.4 million new cases and over 396,792 deaths in 20221. In India, the incidence of PCa has been rising steadily, particularly in urban centers, due to aging demographics and lifestyle transitions. Unlike in Western countries where structured screening programs exist, diagnosis in India is often delayed, and patients frequently present at advanced stages, contributing to poor outcomes2,3. Early detection is critical, as curative treatment options are most effective for localized disease, whereas prognosis worsens significantly in advanced stages. Although, serum prostate-specific antigen (PSA) testing remains the primary screening tool for PCa. However, its limited specificity and sensitivity, often lead to unnecessary biopsies, overdiagnosis and increased patient anxiety, as elevated PSA levels may also arise from benign conditions such as benign prostatic hyperplasia (BPH), prostatitis, or other non-malignant disorders4. These limitations have driven growing interest in non-invasive liquid biopsy markers, which can improve early diagnosis, guide treatment decisions without the discomfort and risks of traditional biopsies and offer advanced risk stratification tools to better inform biopsy decisions5. Urinary biomarkers have gained significant attention because prostatederived cargo is naturally secreted and drained into urine, making it a reliable source for molecular profiling6. Areview by M Salagierski et, al (2010) reported that urinary biomarkers such as prostate cancer antigen 3(PCA3)  \n1Apollo Hospitals Educational and Research Foundation (AHERF), Hyderabad, Telangana, India. 2Exomed Therapeutics Private Ltd., Hyderabad, Telangana, India. 3Apollo Cancer Institute, Jubile","cbCainPRKFlbrgsB","https://ap.wps.com/l/cbCainPRKFlbrgsB","pdf",2195099,12,"English","# Introduction\n## Limitations of PSA and need for noninvasive biomarkers\n## Rationale for urinary extracellular vesicles (UEVs)\n# Methods overview\n## Isolation and characterization of UEVs\n## Gene expression quantification and modeling\n# Results overview\n## Differential expression of six target genes\n## Diagnostic performance and gene panels\n## Relationship with Gleason score and tumor stage","[{\"question\":\"Why are noninvasive biomarkers needed for prostate cancer detection?\",\"answer\":\"PSA remains widely used, but its low specificity can lead to overdiagnosis and unnecessary biopsies. Noninvasive biomarkers can improve early detection and reduce patient burden and anxiety.\"},{\"question\":\"How were urinary extracellular vesicles (UEVs) obtained and validated in the study?\",\"answer\":\"UEVs were isolated from healthy individuals and prostate cancer patients using polyethylene glycol (PEG) precipitation, then characterized by NTA, TEM, and western blotting.\"},{\"question\":\"Which gene models performed best for distinguishing prostate cancer patients from healthy individuals?\",\"answer\":\"A combined six-gene logistic model achieved an AUC of 0.96, while a simplified three-gene panel (AGR2, SPDEF, PCA3) achieved an AUC of 0.954, showing strong diagnostic potential.\"}]","A multi-gene urinary extracellular vesicle mRNA panel as a noninvasive biomarkers for prostate cancer detection | PDF",1790088957,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0335ac311e176730d7039a6336fce428.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8218155659178b39ec107f40fcd138bb.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b91938b04685ee2b84126f1ea16ddad3.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80c3e4b7e8b3de72bc79fba19ce1f51a.webp",980,1287]